Pooja Mathur | Pharmaceutics | Excellence in Research Award

Published-on by Indian Scientist

Pooja Mathur | Pharmaceutics | Excellence in Research Award

GD Goenka University | India

Dr. Pooja Mathur is an accomplished academic and researcher in Pharmaceutics with advanced doctoral training and extensive experience in teaching, research, and academic coordination. She has contributed significantly to pharmaceutical sciences through high-impact publications, books, patents, and interdisciplinary research. Her research interests include nanoformulations, drug delivery systems, phytopharmaceuticals, oncology therapeutics, and translational nanomedicine. She actively serves as a reviewer for reputed international journals and has received multiple recognitions for academic excellence, research output, and institutional contributions, reflecting her strong commitment to innovation and scholarly leadership.

Citation Metrics (Scopus)

150
20
10
5
0

Citations
149

Documents
22

h-index
4

Citations

Documents

h-index

Featured Publications

Subham Preetam | Nano-robots | Editorial Board Member

Published-on by Indian Scientist

Mr. Subham Preetam | Nano-robots | Editorial Board Member

Monash University | India

Mr. Subham Preetam is a distinguished Transfusion Medicine specialist recognized for impactful clinical research, academic contributions, and leadership in advancing evidence-based transfusion practices. With an h-index of 17, a research portfolio of 40 documents, and 1,102 citations across 904 citing documents, Mr. Preetam has established a strong scientific footprint in areas such as apheresis, patient blood management, therapeutic plasma exchange, leukocytapheresis, immunohematology, and transfusion safety. His academic journey includes an MBBS, an MD in Transfusion Medicine, and advanced clinical training through a PDCC in Apheresis and Blood Component Therapy. Professionally, he has served as Senior Resident and faculty in leading national medical institutes, contributing significantly to service development, SOP formulation, staff training, and quality systems in transfusion services. His research interests span clinical apheresis, hemovigilance, transfusion reactions, donor health, PBM strategies, and improving transfusion outcomes. Mr. Preetam has earned recognition through prestigious national awards and has contributed to international working groups, editorial activities, invited sessions, and collaborative projects that strengthen global transfusion medicine practices. His continued dedication reflects a commitment to improving clinical standards, fostering academic excellence, and promoting innovation in transfusion medicine for enhanced patient care.

Profiles: Scopus | Orcid

Featured Publications

Preetam, S., Lata, S., Aditi, Bora, J., Thapliyal, S., Mehta, S., Ramniwas, S., Deshwal, R., Rustagi, S., Talukdar, N., et al. (2025). Exosome-driven biohybrid nanorobots: Bridging nature and nanotechnology in biomedical innovation. RSC Advances. https://doi.org/10.1039/D5RA05296C

Dhasmana, A., Santhanam, A., Dhasmana, K., Malik, S., & Preetam, S. (2025). Innovative smart biosensors for cancer theranostics: A new frontier in detection, diagnosis, and beyond. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100911

Dhasmana, A., Dobhal, P., Sati, A., Santhanam, A., Preetam, S., Malik, S., Joshi, N., Rustagi, S., & Deshwal, R. K. (2025). Synthesis of fungal polysaccharide-based nanoemulsions for cancer treatment. RSC Advances. https://doi.org/10.1039/D5RA01349F

Bhattacharya, T., Das, T., Preetam, S., & Chopra, H. (2025). Cutting-edge developments in agro-waste derived carbon nanomaterials and their multifaceted applications in agriculture: Enhancing crop imaging, nutrient efficiency, and plant health. Zeitschrift für Naturforschung C. https://doi.org/10.1515/znc-2024-0205

Preetam, S., Mishra, R., Thapliyal, S., Rustagi, S., Deshwal, R. K., Ramniwas, S., Dhasmana, A., Rajab, B. S., Alghamdi, S., & Malik, S. (2025). Bioactive coatings for cardiovascular stents: Modulating immune response for enhanced performance. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01166

Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Published-on by Indian Scientist

Mr. Rishabh Chalotra | Metabolic Disorders | Young Researcher Award

Central University of Punjab | India

Rishabh Chalotra is a CSIR-Senior Research Fellow and doctoral scholar at the Laboratory of Neuroendocrinology and Metabolic Disorders, Department of Pharmacology, Central University of Punjab. His research focuses on addressing the complexities of Metabolic Syndrome through preclinical studies, exploring the therapeutic potential of natural phytoconstituents, and developing herbal-based solutions for improved clinical outcomes. He holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy, with extensive experience in animal models, biochemical assays, pharmacokinetic studies, ELISA, RT-PCR, flow cytometry, and other advanced laboratory techniques. Rishabh has contributed to 18 peer-reviewed articles, six book chapters, and four patents, with his work cited 127 times, reflecting an h-index of 6 and an i10-index of 5. His publications explore metabolic disorders, diabetic complications, neurodegenerative diseases, and drug discovery, highlighting the role of flavonoids and natural compounds in therapeutic interventions. He has received the Young Investigator Award from the Indian Pharmacological Society and is a lifetime member of professional societies including the Indian Pharmacological Society, American Society for Microbiology, and British Pharmacological Society. His research combines experimental pharmacology with translational applications to bridge knowledge gaps and improve patient outcomes, positioning him as a promising contributor to global pharmacological research.

Profile: Google Scholar

Featured Publication

Chauhan, S., Chalotra, R., Rathi, A., Saini, M., Deol, S., Lard, M., & Gupta, S. (2023). Current approaches in healing of wounds in diabetes and diabetic foot ulcers. Current Bioactive Compounds, 19(3), 104–121.

Chalotra, R., Gupta, T., Chib, S., Amanat, M., Kumar, P., & Singh, R. (2024). Treatment of diabetic complications: Do flavonoids hold the keys? Critical Reviews in Food Science and Nutrition, 64(30), 11091–11112.

Maqbool, M., Chaudhary, K., Chalotra, R., Chauhan, S., & Dahiya, R. S. (2024). Phyto-pharmacology of most common Indian culinary spices and their potential in developing new pharmaceutical therapies. Current Traditional Medicine, 10(2), 117–140.

Sharma, K., Chib, S., Gupta, A., Singh, R., & Chalotra, R. (2024). Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease. Molecular Biology Reports, 51(1), 586.

Chib, S., Dutta, B. J., Chalotra, R., Abubakar, M., Kumar, P., Singh, T. G., & Singh, R. (2025). Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease. Phytotherapy Research, 39(2), 747–775.

Anupam Kanti Bag | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Anupam Kanti Bag | Pharmacology | Best Researcher Award

Dr. B.C. Roy College of Pharmacy and Allied Health Sciences |India

Dr. Anupam Kanti Bag is an accomplished pharmacology professional with strong academic and research credentials, reflected through 142 citations, an h-index of 3, and 3 i10-index publications, demonstrating consistent scholarly impact. His expertise spans microscopy, molecular biology, behavioral analysis, molecular docking, and network pharmacology, supported by extensive laboratory experience and a solid background in pharmaceutical sciences. He has significantly contributed to innovation through multiple national and international patents in drug formulation, medical device design, and pharmacokinetic enhancement, along with authoring books and contributing chapters in emerging areas of neurodegenerative disease research. His funded research work includes projects focusing on phytochemical formulations and nano-based therapeutic applications. Dr. Bag has served in various academic, administrative, and accreditation roles, including NAAC/NBA coordination, placement operations, exam cell management, and institutional leadership responsibilities across reputed pharmacy colleges. His technical skills extend to tools such as Pyrex, Pymol, Chimera, and Biovia Studio, combined with proficiency in cell culture handling, gene assays, ADR reporting, and laboratory instrumentation. Recognized with awards for academic excellence, mentoring, and scientific presentations, he continues to contribute to the advancement of pharmacology research with dedication to innovation, collaboration, and student development.

Profile: Google Scholar

Featured Publications

Bag, A. K., & Mumtaz, S. M. F. (2013). Hepatoprotective and nephroprotective activity of hydroalcoholic extract of Ipomoea staphylina leaves. Bangladesh Journal of Pharmacology, 8(3), 263–268.

Subramaniyan, V., Shaik, S., Bag, A., Manavalan, G., & Chandiran, S. (2018). Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin-induced nephrotoxicity in experimental rats. Pakistan Journal of Pharmaceutical Sciences, 31(2), 509–516.

Mumtaz, S. M. F., Paul, S., & Bag, A. K. (2013). Effect of Sechium edule on chemical-induced kidney damage in experimental animals. Bangladesh Journal of Pharmacology, 8(1), 28–35.

Bag, A. K., & Hiremath, S. R. R. (2023). Neuropathic pain and its management. Indian Journal of Pharmacy Practice, 16(3).

Verma, P., Munirangappa, H., Bag, A. K., & Purushottam, H. (2023). Amelioration of hyperglycemia by hydroalcoholic extract of leaves of Ecbolium viride against experimental type II model in rats.

Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Published-on by Indian Scientist

Mr. Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Chitkara University Punjab | India

Ankush Kumar is a dedicated pharmaceutical researcher whose work spans medicinal chemistry, molecular modeling, and targeted drug design with a strong focus on anticancer therapeutics. He holds a solid academic foundation with qualifications in pharmaceutical chemistry and extensive research training that includes computational drug design, structure-activity exploration, and medicinal insights into heterocyclic scaffolds. His professional experience includes serving as a Junior Research Fellow and working as an Assistant Professor across multiple academic institutions, where he contributed to teaching, mentoring, and research development. His research outputs reflect a strong contribution to oncology-oriented drug discovery, with publications covering molecular targets, biomarkers, EGFR inhibition, heterocyclic synthesis, and computational repurposing studies. He has authored numerous research papers in reputed journals, contributing to a total of 561 citations, supported by an h-index of 6 and i10-index of 4, demonstrating the growing influence of his scientific contributions. His work includes book chapters and multiple peer-reviewed articles that highlight new therapeutic strategies and structural insights into various biological targets. He has received academic distinctions such as top positions in academic competitions and has served as a reviewer for international journals, further reflecting his scholarly engagement. Overall, his research trajectory reflects a commitment to advancing pharmaceutical innovation and precision-driven drug discovery.

Profile: Google Scholar

Featured Publications

Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Jha, S. K., et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 105.

Kumar, A., Sehgal, A., Singh, S., Sharma, N., Yadav, S., Rashid, S., Ali, N., et al. (2023). Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer. International Journal of Biological Macromolecules, Article 126595.

Zheng, M., Kumar, A., Sharma, V., Sehgal, A., Wal, P., Shinde, N. V., Kawaduji, B. S., et al. (2024). Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Frontiers in Cell and Developmental Biology, 12, Article 1353860.

Kumar, A., Kumar, B., & Bhatia, R. (2023). Design, synthesis, molecular docking, and biological evaluation of isatin-based fused heterocycles as epidermal growth factor receptor inhibitors. Assay and Drug Development Technologies, 21(5), 222–233.

Kumar, A., Narang, R. K., & Bhatia, R. (2023). Recent advancements in NS5B inhibitors (2011–2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure, 1293, Article 136272.

Amit Nayak | Disease Survillance | Best Researcher Award

Published-on by Indian Scientist

Dr. Amit Nayak | Disease Survillance | Best Researcher Award

Central India Intitute of Medical Sciences | India

Dr. Amit R. Nayak is a Senior Research Consultant and Capacity Building Lead at the Central India Institute of Medical Sciences – Advanced Research Centre. He holds a B.Sc. in Biotechnology, an M.Sc. in Biochemistry, and a Ph.D. in Biochemistry with research focused on identifying biomarkers and therapeutic agents related to acute neurological disorders. Over the course of his research career, he has worked extensively in clinical and translational neuroscience, specializing in neuroinfection, neuroinflammation, molecular diagnostics, biomarker discovery, metagenomics and infectious disease surveillance. He has contributed to more than 45 peer-reviewed publications, resulting in over 580 citations, an h-index of 15, and an i10-index of 19, reflecting the broader impact of his scientific work. His roles have included leading and coordinating multiple national and international collaborative projects as Principal Investigator and Co-Investigator funded by reputed agencies. He is also actively involved in diagnostic innovation, clinical laboratory management, ethical review processes, and research capacity development. His research output supports advancements in understanding and managing infectious and neurological disorders. He continues to contribute toward translational research that bridges laboratory investigations with meaningful clinical applications.

Profile: Scopus

Featured Publications

Nayak, A. R., et al. (2025). A biomarker based peptide immunoassay for Clostridioides difficile: Insights from Central India. International Journal of Peptide Research and Therapeutics.

Nayak, A. R., et al. (2025). Application of machine learning to identify factors affecting prevalence of Brucella: A Central India study. Conference Presentation (Open Access).

Nayak, A. R., et al. (2024). In vitro toxicity assessment of bioavailable iron in coal varieties of Central India.

Sourav Mukherjee | Transfusion Medicine | Best Researcher Award

Published-on by Indian Scientist

Dr. Sourav Mukherjee | Transfusion  Medicine | Best Researcher Award

S.A.Engineering College | India

Dr. G. Deepana is a civil engineering researcher and academician with a strong contribution to structural and sustainable construction materials. She has earned her doctoral degree in Civil Engineering with prior specialization in Structural Engineering, and has consistently demonstrated academic excellence throughout her education. Her research profile reflects 11 citations, an h-index of 2, and several indexed publications across SCI and Scopus-listed journals. She has published impactful work in areas such as ferrocement composites, sustainable green concrete materials, construction waste utilization, and performance enhancement of structural elements. Her SCI publications include studies on ferrocement wall panel behavior and agro-waste reinforced composites, alongside multiple Scopus-indexed contributions exploring durability, material characterization, and sustainability in civil engineering. She has also presented her work at international and national conferences, contributing to global discussions on innovative construction materials. In addition to research, she has academic experience as an Assistant Professor, handling core civil engineering courses and laboratories, while guiding students in both theoretical and practical learning. Her research interests include concrete technology, strength of materials, ferrocement, structural durability, and sustainable infrastructure development. She aims to continue advancing environmentally responsible construction practices and contribute meaningfully to academic and engineering communities.

Profile: Scopus

Featured Publications

Mukherjee, S., Sekhar Das, S., Chowdhury, S., Ghosh, S., & Bera, S. C. (2025). HIV screening in blood donation: Diagnostic accuracy of chemiluminescence and rapid test compared to nucleic acid test in a large-scale Eastern India cohort. Transfusion and Apheresis Science. https://doi.org/10.1016/j.transci.2025.104261

Renu Chaudhary | Microbiology | Best Researcher Award

Published-on by Indian Scientist

Dr. Renu Chaudhary | Microbiology | Best Researcher Award

CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi | India

Dr. Renu Chaudhary is a dedicated microbiologist and molecular biologist with extensive expertise in genomics, genome editing (CRISPR/Cas9), and antifungal research. Her work spans transcriptomics, structural biology, phenotypic analysis, and the study of stress response mechanisms in pathogenic fungi and Mycobacterium tuberculosis. She has contributed significantly to isolating and characterizing antimicrobial bacteria from plant rhizospheres, developing novel antifungal compounds, and exploring molecular targets for antifungal and antibacterial therapeutics. Dr. Chaudhary has authored numerous peer-reviewed articles and book chapters, with a total of 156 citations, an h-index of 6, and an i10-index of 4, reflecting her research impact and scholarly recognition. She has been involved in leading and collaborating on several funded projects, including fellowships from national science agencies, focusing on fungal diagnostics, drug resistance mechanisms, and metal homeostasis in microbes. Her research interests include antifungal resistance, microbial genomics, protein therapeutics, and biotechnological applications of fungi. Recognized for excellence in presentations and publications, she has received awards for best poster and paper contributions at national and international conferences. Dr. Chaudhary combines deep scientific knowledge with analytical rigor, driving translational research aimed at innovative solutions for infectious disease management and microbial therapeutics.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Chaudhary, R., Singh, B., Kumar, M., Gakhar, S. K., Saini, A. K., Parmar, V. S., … [et al.]. (2015). Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases. Drug Metabolism Reviews, 47(3), 281–290.

Balhara, M., Chaudhary, R., Ruhil, S., Singh, B., Dahiya, N., Parmar, V. S., … [et al.]. (2016). Siderophores; iron scavengers: The novel & promising targets for pathogen specific antifungal therapy. Expert Opinion on Therapeutic Targets, 20(12), 1477–1489.

Ahlawat, S., Chaudhary, R., Dangi, M., Bala, K., Singh, M., Chhillar, A. K. (2020). Advances in tuberculous meningitis diagnosis. Expert Review of Molecular Diagnostics, 20(12), 1229–1241.

Chaudhary, R., Balhara, M., Jangir, D. K., Dangi, M., Dangi, M., Chhillar, A. K. (2019). In silico protein interaction network analysis of virulence proteins associated with invasive aspergillosis for drug discovery. Current Topics in Medicinal Chemistry, 19(2), 146–155.

Khatri, S., Kumar, M., Phougat, N., Chaudhary, R., Chhillar, A. K. (2016). Perspectives on phytochemicals as antibacterial agents: An outstanding contribution to modern therapeutics. Mini Reviews in Medicinal Chemistry, 16(4), 290–308.

Pooja Gupta | Microbial Pathogenesis | Best Researcher Award

Published-on by Indian Scientist

Dr. Pooja Gupta | Microbial Pathogenesis | Best Researcher Award

Presidency University, Kolkata | India

Pooja Gupta is a postdoctoral researcher in critical care research at a leading cancer institute, where her work focuses on lung infection models and the role of neutrophils in infection among cancer patients. She earned her Ph.D. in Molecular Microbiology and Immunology from CSIR–Central Drug Research Institute, where she investigated novel and unconventional molecules as next-generation therapeutics, including quorum sensing inhibitors and antimicrobial peptides against drug-resistant pathogens. With a strong foundation in microbiology and immunology, she has developed expertise in bacterial communication systems, anti-virulence strategies, biofilm inhibition, protein modeling, molecular cloning, animal models of infection, and immunological assays. She has presented her work at national and international conferences, contributed to peer-reviewed publications, and co-authored patents based on her discoveries. Her research interests lie in quorum sensing, antimicrobial peptide design, host–pathogen interactions, infection in cancer, and translational microbiology. She is passionate about bridging basic science with applied therapeutics to combat antibiotic resistance and improve infection outcomes in vulnerable patient populations. Recognized for her scientific contributions, she continues to pursue innovative approaches at the interface of microbiology, immunology, and oncology with the goal of advancing next-generation anti-infective strategies for human health.

Profile: Orcid

Featured Publications

Gupta, P., Yadav, P., Lata, M., Chaudhary, S., Telang, V., Kishore, R., Kishan, J., Goswami, K., Arockiaraj, J., Singh, R., & others. (2025). Potential next generation targets for antibacterial agent’s discovery and development. European Journal of Medicinal Chemistry.

Arya, C. G., Kishore, R., Gupta, P., Gondru, R., Arockiaraj, J., Pasupuleti, M., Chandrakanth, M., Punya, V. P., & Banothu, J. (2024). Identification of coumarin–benzimidazole hybrids as potential antibacterial agents: Synthesis, in vitro and in vivo biological assessment, and ADMET prediction. Bioorganic & Medicinal Chemistry Letters.

Lata, M., Telang, V., Gupta, P., Pant, G., Kalyan, M., Arockiaraj, J., & Pasupuleti, M. (2024). Synthetic short cryptic antimicrobial peptides as templates for the development of novel biotherapeutics against WHO priority pathogen. International Journal of Peptide Research and Therapeutics.

Lata, M., Telang, V., Gupta, P., Pant, G., Kalyan, M., Arockiaraj, J., & Pasupuleti, M. (2023). Evolutionary and in silico guided development of novel peptide analogues for antibacterial activity against ESKAPE pathogens. Current Research in Microbial Sciences.

Biswas, S., Rahaman, T., Gupta, P., Mitra, R., Dutta, S., Kharlyngdoh, E., Guha, S., Ganguly, J., Pal, A., & Das, M. (2022). Cellulose and lignin profiling in seven economically important bamboo species of India by anatomical, biochemical, FTIR spectroscopy and thermogravimetric analysis. Biomass and Bioenergy.

 

Bijesh Biswal | Cell Biology | Excellence in Research Award

Published-on by Indian Scientist

Dr. Bijesh Biswal | Cell Biology | Excellence in Research Award

National Institute of Technology Rourkela | India

Dr. Bijesh Kumar Biswal is an Associate Professor at the Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, India. He holds a Ph.D. in Cancer Biology from IIT Madras and has completed postdoctoral research at Rutgers University and Dartmouth College, USA. His research focuses on cancer biology, particularly transcriptional regulation, drug resistance mechanisms, and exosome-mediated drug delivery. Dr. Biswal has authored over 60 publications and has been cited more than 1,100 times, reflecting his significant contribution to the field. He has mentored 3 Ph.D. students and 15 Master’s students, with several ongoing research projects. His work has been recognized with awards such as the Best Faculty Advisor Award from NIT Rourkela and the Early Career Research Award from SERB, DST, New Delhi. Dr. Biswal is a life member of the Indian Association of Cancer Research and the Society of Biochemists India. His research continues to influence cancer therapeutics and drug resistance studies.

Profiles: Google Scholar | Orcid

Featured Publication

Tripathi, S. K., Panda, M., & Biswal, B. K. (2019). Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology, 125, 566–582.

Tripathi, S. K., & Biswal, B. K. (2020). Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacological Research, 156, 104772.

Panda, M., Tripathi, S. K., & Biswal, B. K. (2021). SOX9: An emerging driving factor from cancer progression to drug resistance. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer, 1875(2), 188517.

Panda, M., & Biswal, B. K. (2019). Cell signaling and cancer: A mechanistic insight into drug resistance. Molecular Biology Reports, 46(5), 5645–5659.

Mao, P., Hever-Jardine, M. P., Rahme, G. J., Yang, E., Tam, J., Kodali, A., Biswal, B., … (2013). Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma. PLoS One, 8(11), e81803.